Pricing

Competitive Pricing at Every Volume

Avanta Pharma Group works through established 503A pharmacy partner relationships and combines purchasing volume across the clinics it supplies to negotiate rates that scale. Whether a practice orders a couple of dozen vials a month or several hundred, pricing is banded rather than gated behind a large minimum commitment, and the entry band is orderable at published list pricing without a call.

Band 125-49 orders a month$80 per vial: list price, orderable with no call
Band 250-99 orders a month$75 per vial
Band 3100-199 orders a month$70 per vial
Band 4200+ orders a month$65 per vial, the lowest published price

Published list pricing

Semaglutide 1 mL (2.5 mg/mL): from $65per vial at 200+ a month
Tirzepatide 1 mL (10 mg/mL): from $100per vial

List pricing orderable with no call
Volume pricing quoted on a call
Shipping $25 standard, $45 overnight
To the clinic or direct to the patient

Of the 19 suppliers Clinic Partner Guide tracks (12 sourcing platforms and 7 pharmacies), 2 publish per-vial rates a clinic can read before making contact, and Avanta Pharma Group is one of them. Most of this market quotes only after a call or a provider account, which is why the figures above are unusual rather than ordinary. They are Avanta Pharma Group’s own published list rates, read from its site on 2026-10-22, and you can check them there.

Visit Avanta Pharma Group See who else publishes pricing

Rates shown are Avanta Pharma Group’s published list pricing and may change. Volume pricing is quoted per clinic, so the rate a practice pays depends on its own monthly volume, formulation and terms. Avanta Pharma Group is a pharmacy sourcing partner: compounding is performed by its 503A pharmacy partners rather than by Avanta Pharma Group itself.

12 compounding sourcing platforms compared, as open data

Yes. As of 19 September 2026, Clinic Partner Guide publishes the Compounded Sourcing Platform Index as free CSV and JSON under CC BY 4.0. It compares 12 compounded-medication sourcing platforms for licensed clinics on 7 criteria, scored 2026-08-31 from each platform's own public pages. It records what platforms publish, not clinical quality.

Written by Chelsea CooperReviewed by Elizabeth WarnerUpdated September 202611 sources Methodology

What the Compounded Sourcing Platform Index is

Yes, open comparison data exists. As of 19 September 2026, Clinic Partner Guide's Compounded Sourcing Platform Index Source 1 compares 12 compounded-medication sourcing platforms for licensed clinics on 7 weighted criteria, each score read from the platform's own public pages (scored 2026-08-31)Source 2. The full data is free to download as CSV Source 2 and JSON Source 3 under CC BY 4.0.

Two more platforms, OnlyScripts and Pharm503, are listed with the reason they were not scored rather than dropped.Source 2

Clinic Partner Guide publishes the index and has a commercial affiliation with its highest-scoring platform, Avanta Pharma Group (5.0 out of 5, scored 2026-08-31)Source 2. Read every number below with that in mind.

A low score describes disclosure, not service. The methodology: "A platform that discloses little scores lower on transparency, which is a statement about its disclosure and not about its service."Source 4

Disclosure: Clinic Partner Guide has a commercial affiliation with Avanta Pharma Group. Avanta is scored on the same criteria as every platform in the index, and no payment changes a score, a rank or an award. See our commercial disclosure: https://clinicpartnerguide.com/commercial-disclosure/Source 9

What each row contains

The CSV has 14 rows (12 scored, 2 listed as not scored) and 28 columns.Source 2
platform, host, category: the supplier and its kind of business.
overall_of_5: the weighted score, 0 to 5.
criteria_evidenced_pct: the share of criteria weight the platform published enough on to be judged.
verified_at: the date the pages were read, 2026-08-31 for every row.
primary_document_url: a price list or terms page, where one is published.
For each of the 7 criteria: <criterion>_score, <criterion>_source and <criterion>_reason, the sentence justifying the score.
The JSON holds the same rows plus each criterion's weight and definition, the license and the scale.Source 3

What the data shows about what platforms publish to clinics

"Platform" covers unlike businesses. Of the 12 scored rows, 5 are multi-pharmacy marketplaces (AutoPilotRx, Fizy Health, VitaRelay, Ironsail Pharma / ImpetusOne, CLR RX), 4 are directories, 1 is a GPO or buying network (The Banyan Network), 1 is a quote engine (CompoundingFinder) and 1 is a direct supply partner (Avanta Pharma Group), scored 2026-08-31.Source 2 A clinic comparing "platforms" is comparing different business models.

Half describe an ordering system. 6 of 12 score 4 or 5 on ordering workflow (scored 2026-08-31): Avanta Pharma Group, AutoPilotRx and Fizy Health at 5; VitaRelay, Ironsail and CLR RX at 4.Source 2 The other 6 offer discovery, quotes or buying terms. The directories record no ordering function, CompoundingFinder's reason says "so it is not a reorder workflow", and The Banyan Network's says "no portal is described".Source 2

5 of 12 publish nothing about price that could be scored (scored 2026-08-31). Three are ordering platforms whose entry is a call or a demo: VitaRelay ("No pricing is published; entry is book a call."), Ironsail ("No pricing is published; the product sits behind a demo.") and CLR RX ("No pricing is published; entry is a private demo request.").Source 2 The other two are Find My Compounder and the APC / A4PC Pharmacy Locator. See which platforms publish clinic pricing Source 5.

Publishing something about price is not publishing a price. Of the 7 platforms that publish something, 1 reason contains price figures: Avanta Pharma Group's, which records per-vial list prices and three volume tiers (up to 24, 25 plus, 100 plus), scored 2026-08-31.Source 2 The Banyan Network's reason reads: "The rates themselves are not published."Source 2

6 of 12 publish a price list or terms a clinic can read before signing up (scored 2026-08-31): Avanta Pharma Group, Fizy Health, VitaRelay, CompoundingFinder, Find My Chemist and Find My Compounder.Source 3

Turnaround is the least-published fact. 6 of 12 publish nothing about turnaround that could be scored, more than any other criterion (scored 2026-08-31). Of the 6 that were scored, 4 reasons state there is no commitment: Fizy Health ("No turnaround commitment."), VitaRelay ("without a turnaround commitment"), CLR RX ("without a published turnaround") and The Banyan Network ("No turnaround is published.").Source 2 CompoundingFinder's "1 to 2 business days" is, in its reason's words, "a wait for quotes rather than fulfilment".Source 2 See which platforms publish a turnaround time Source 6.

Unknowns cluster in three criteria. 12 of 84 criterion cells are not stated: 6 in turnaround, 5 in pricing transparency and 1 in security posture (Ironsail: "Nothing published on the public site."), scored 2026-08-31.Source 3 Ordering workflow, direct accountability and onboarding speed have no unknowns.Source 3

No marketplace, network, directory or quote engine in the index is recorded as naming an account owner (scored 2026-08-31).Source 2 The reasons for AutoPilotRx, Fizy Health and The Banyan Network record no named account owner; CLR RX's says "accountability sits with the platform rather than a named contact"; CompoundingFinder's says "The service ends at introduction".Source 2

Two ordering platforms put a demo in the entry path, 2 of the 6 (scored 2026-08-31): Ironsail ("Entry is sign up or book a demo. A demo gate delays a first order.") and CLR RX ("Entry is a private demo request.").Source 2 VitaRelay offers self-serve registration "alongside book a call".Source 2 State coverage is compared separately on the multi-state coverage page Source 7.

How the scores are made

The index uses 7 criteria, weighted according to our published methodology Source 4 (v1.0, updated August 2026). Ordering workflow, pricing transparency and direct accountability carry 20% each. Multi-state coverage, turnaround, security posture and onboarding speed carry 10% each.Source 3

Silence is excluded rather than scored low: "A criterion neither published nor confirmed to us is recorded as unknown and excluded from the weighted average rather than scored low, so silence is not punished."Source 4The methodology adds: "That does mean two overall scores can rest on different numbers of criteria."Source 4

That shows in the data. Criteria evidenced runs from 60% to 100%, with a mean of 85.8% computed from the JSON (scored 2026-08-31).Source 3 Ironsail Pharma / ImpetusOne ranks 5th at 3.33 on 60% of criteria weight evidenced, above CLR RX (3.25, 80%) and The Banyan Network (3.10, 100%).Source 3

Under the methodology, a criterion can be scored from what a platform publishes or from what it confirms to Clinic Partner Guide.Source 4 In this version, all 84 criterion cells cite a published page, so anyone can check every score against the platform's own site (scored 2026-08-31).Source 3

How this differs from GLP-1 price indexes and pharmacy directories

Consumer GLP-1 price indexes record what patients pay telehealth programs. This index records what compounded-medication sourcing platforms publish to licensed clinics: ordering, pricing, accountability, states, turnaround, security and onboarding.Source 1 It makes no clinical assessment.

Pharmacy directories list pharmacies. Here, 4 directories are themselves rows, scored on the same criteria: the Peptide Association Pharmacy Directory, Find My Chemist, Find My Compounder and the APC / A4PC Pharmacy Locator (scored 2026-08-31).Source 2 A search on 19 September 2026 found no other open dataset on clinic sourcing platforms.

Regulatory context for clinics reading supplier data next to GLP-1 pricing: FDA's shortage listings for tirzepatide (December 2024) and semaglutide (February 2025) have ended, and FDA has since acted against marketing of compounded GLP-1s; what a 503A pharmacy may compound is patient-specific and varies by state. Source: fda.gov, "FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize", read 2026-09-19.Source 11

What the index does not cover

The index does not assess clinical quality, formulations or outcomes. It compares sourcing platforms, not 503A pharmacies themselves. For the choice between the two models, see buying direct from a 503A pharmacy vs a sourcing partner Source 8.

Two platforms are listed but not scored. OnlyScripts "Returned HTTP 503 on every attempt on 2026-08-29, so none of its claims could be read from its own pages." Pharm503 "States Join Waitlist and now accepting early access signups, so it is pre-launch."Source 2

The scores are a snapshot. In the methodology's words: "Scores are a snapshot of published information on the date shown."Source 4Supplier pages can change after 31 August 2026, so check the platform's own page on the day you decide.

How a clinic can use it in a supplier shortlist

Filter by the kind of supplier you need.
Download the CSV and filter the category column. A directory, a marketplace and a direct supply partner answer different procurement questions.Source 2
Read the evidence share beside the score.
Put criteria_evidenced_pct next to overall_of_5. Two similar scores can rest on very different amounts of evidence.Source 3
Read the reason sentence.
Each <criterion>_reason column states what the platform published.Source 2
Turn the gaps into sales-call questions.
Where a cell is not published, ask the supplier directly: what will I pay at my volume, what fulfillment time do you commit to in writing, and who owns my account?
Read the terms before you sign up.
Follow primary_document_url where it exists.Source 3
Check the date.
Read verified_at, then open the supplier's own page on the day you decide.Source 2

How to cite and reuse the data

The license is CC BY 4.0 Source 10. The attribution string set in the CSV header and the JSON is "Compounded Sourcing Platform Index, clinicpartnerguide.com".Source 2 A citation that carries the date: Compounded Sourcing Platform Index, clinicpartnerguide.com, scored 2026-08-31, CC BY 4.0.

The file URLs are https://clinicpartnerguide.com/sourcing-platform-index.csv Source 2 and https://clinicpartnerguide.com/sourcing-platform-index.json Source 3. The CSV downloads as sourcing-platform-index-2026-08-31.csv, so a saved copy keeps its scoring date.

Questions clinics ask

Is there a free spreadsheet that compares compounding pharmacy sourcing platforms?

Yes. The Compounded Sourcing Platform Index CSV compares 12 sourcing platforms for licensed clinics on 7 criteria (scored 2026-08-31), free under CC BY 4.0:Source 2 https://clinicpartnerguide.com/sourcing-platform-index.csv

Which platforms show clinic pricing before a sales call?

7 of 12 platforms publish something about price, and 5 publish nothing that could be scored: VitaRelay, Ironsail Pharma / ImpetusOne, CLR RX, Find My Compounder and the APC / A4PC Pharmacy Locator (scored 2026-08-31).Source 2 Detail: the pricing transparency page Source 5.

Can I use this data in my own supplier review or a deck for my partners?

The index page states the data "is offered under CC BY 4.0, so you may republish or build on it with attribution to Compounded Sourcing Platform Index, clinicpartnerguide.com."Source 1Keep the attribution and the scoring date with any table you reuse.

How old is the data, and how will I know when a score changes?

Every row carries its verified_at date, 2026-08-31 for all 12 scored platforms.Source 2 The scores are a snapshot of what platforms published on that date.Source 4 A fixed re-scoring schedule is not published. Check the supplier's own page on the day you decide.

Does Clinic Partner Guide get paid by any platform in the index?

Sources

1Compounded Sourcing Platform Indexclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
2Compounded Sourcing Platform Index, CSV exportclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
3Compounded Sourcing Platform Index, JSON exportclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
4Methodology, v1.0clinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
5Which platforms publish clinic pricingclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
6Compounding pharmacies that publish turnaround timesclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
7Compounding pharmacy multi-state coverageclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
8Buying direct from a 503A pharmacy vs a sourcing partnerclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
9Commercial disclosureclinicpartnerguide.com
Official primary sourceClinic Partner GuideRetrieved September 19, 2026
10Creative Commons Attribution 4.0 International (CC BY 4.0)creativecommons.org
Official primary sourceCreative CommonsRetrieved September 19, 2026
11FDA clarifies policies for compounders as national GLP-1 supply begins to stabilizefda.gov
Regulatory / governmentU.S. Food and Drug AdministrationRetrieved September 19, 2026

What each 503A pharmacy partner publishes about pricing

There is no standard 503A compounding pharmacy price for clinics, and the reason is disclosure rather than variation alone: of the 12 sourcing platforms in this index, one publishes actual clinic rates. The rest either describe how pricing works without saying what it costs, or publish nothing about price and quote only after a call. Read as at 2026-08-31, except where a row gives a later date.

Each platform in the index, what it discloses about clinic pricing, and the pricing transparency score that follows from it, as at 2026-08-31, except where a row gives a later date
Platform	Clinic pricing	What is published
Avanta Pharma Group	Rates published	Publishes a full per-vial retail schedule for compounded semaglutide and tirzepatide by concentration and vial size (semaglutide 1 mL at 2.5 mg/mL $80, falling to $65 at 200+ orders a month; tirzepatide from $100 per 1 mL vial), four monthly-volume bands (25-49, 50-99, 100-199, 200+) and an on-site price comparison calculator. List pricing is orderable with no call; volume pricing is quoted on a call.Re-read 2026-10-22
AutoPilotRx	Model only, no rates	States pricing, state licensing and formularies are comparable in-portal and free for providers. No per-clinic negotiated pricing is stated.
Fizy Health	Model only, no rates	States pass-through pricing and zero platform fee. Pass-through is the pharmacy price rather than a per-clinic negotiated rate.
The Banyan Network	Model only, no rates	Publishes negotiated per-partner rates, net-30 terms, no membership or joining fees, and an all-inclusive definition covering medication, supplies, dispensing fees and shipping. States that rates depend on category, volume and partner, and are fixed in the agreement before a first order. No rate card or tiers are published.Re-read 2026-10-18
CompoundingFinder	Model only, no rates	Compares pharmacies by price, turnaround, shipping and inactive ingredients, free and with no obligation.
Peptide Association Pharmacy Directory	Model only, no rates	States price ranges are tracked alongside accreditation and compounds.
Find My Chemist	Model only, no rates	Invites submitted prices and shows price information, but not provider-negotiated rates.
VitaRelay	Nothing published	No pricing is published; entry is book a call.
Ironsail Pharma / ImpetusOne	Nothing published	No pricing is published; the product sits behind a demo.
CLR RX	Nothing published	No pricing is published; entry is a private demo request.
Find My Compounder	Nothing published	No pricing is published.
APC / A4PC Pharmacy Locator	Nothing published	No pricing is published.

Pricing shown is what each provider published at the time we recorded it and may change. Actual pricing varies by product, formulation, order volume, shipping, pharmacy, location and commercial terms. Confirm current pricing directly with the provider.